" class="no-js "lang="en-US"> Lewis Johnson-Pitt, Author at Pharmtech Focus - Page 23 of 35
Tuesday, January 31, 2023

Sort by:

Date

Top Post

ProPharma Acquires UK Based Digital Lab Consulting

ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the […]

Wellbeing Subsidiary KGK Science Awarded Cannabis Research License from Health Canada

Wellbeing Digital Sciences, an evidence-based mental healthcare company focused on the development and implementation of […]

AppliedVR Awarded Contract with VHA Innovation Ecosystem, a division of the United States Department of Veterans Affairs

AppliedVR, an immersive therapeutics (ITx) pioneer advancing a novel, virtual reality-based approach to medicine, has […]

Horizon Therapeutics Announces First Subject Dosed in Phase 1 Trial Evaluating HZN-457 for the Treatment of Gout

Horizon Therapeutics has announced the first subject has been dosed in a Phase 1 randomized, […]

CDR-Life Announces the Appointment of Nicole Onetto, MD, MSc, to Board of Directors

CDR-Life, a biotechnology company pioneering a new and differentiated class of highly tumor-selective immuno-oncology therapeutics […]

Dantari Debuts with $47 Million Series A to Advance Best-in-Class Targeted Medicines for Solid Tumors

Dantari, a clinical-stage biotechnology company developing best-in-class targeted therapeutics for the treatment of cancers and […]

Abiogen Pharma Acquires German Pharmaceutical Company, Altamedics

Abiogen Pharma has completed the acquisition of the German pharmaceutical distribution company Altamedics GmbH which […]

Generate Biomedicines Demonstrates a Novel Method of Reducing Immunogenicity through Protein Re-surfacing

Generate Biomedicines has announced that it has published data in the peer-reviewed journal Frontiers in […]

Tomorrow Health Fully Automates Order Lifecycle For Full Spectrum Of Durable Medical Equipment

Tomorrow Health, a healthcare technology company enabling more efficient and reliable home-based care, has announced […]

Hansa Biopharma Announces Reimbursement in Italy for Idefirix as Desensitization Treatment for Highly Sensitized Patients in Kidney Transplantation

Hansa Biopharma, a pioneer in enzyme technology for rare immunological conditions, has announced that the […]

BRIM Biotechnology Receives FDA Orphan Drug Designation for BRM424 to Treat Neurotrophic Keratitis

BRIM Biotechnology is pleased to announce that the US Food and Drug Administration (FDA) has […]

  1. MedRhythms Feasibility Study Shows Positive Topline Results in Parkinson’s Disease Read more
  2. Ionis receives FDA Fast Track designation for Olezarsen in patients with Familial Chylomicronemia Syndrome Read more
  3. Sensorion and EVEON Collaborating to Develop an Injection System for the Delivery of Gene Therapy Treatments Into the Inner Ear Read more
  4. Qurient Announces Dosing of First Patient in Clinical Study for the Treatment of Patients with Solid Tumors Read more
  5. Marinus Pharmaceuticals Appoints Christine Silverstein to its Board of Directors Read more